134 related articles for article (PubMed ID: 28888784)
1. Malignant ascites determine the transmesothelial invasion of ovarian cancer cells.
Mikuła-Pietrasik J; Uruski P; Szubert S; Szpurek D; Sajdak S; Tykarski A; Książek K
Int J Biochem Cell Biol; 2017 Nov; 92():6-13. PubMed ID: 28888784
[TBL] [Abstract][Full Text] [Related]
2. Senescence-related deterioration of intercellular junctions in the peritoneal mesothelium promotes the transmesothelial invasion of ovarian cancer cells.
Pakuła M; Witucka A; Uruski P; Radziemski A; Moszyński R; Szpurek D; Maksin K; Woźniak A; Sajdak S; Tykarski A; Mikuła-Pietrasik J; Książek K
Sci Rep; 2019 May; 9(1):7587. PubMed ID: 31110245
[TBL] [Abstract][Full Text] [Related]
3. Biochemical composition of malignant ascites determines high aggressiveness of undifferentiated ovarian tumors.
Mikuła-Pietrasik J; Uruski P; Szubert S; Moszyński R; Szpurek D; Sajdak S; Tykarski A; Książek K
Med Oncol; 2016 Aug; 33(8):94. PubMed ID: 27431203
[TBL] [Abstract][Full Text] [Related]
4. The Epithelial-Mesenchymal Transition Initiated by Malignant Ascites Underlies the Transmesothelial Invasion of Ovarian Cancer Cells.
Pakuła M; Mikuła-Pietrasik J; Witucka A; Kostka-Jeziorny K; Uruski P; Moszyński R; Naumowicz E; Sajdak S; Tykarski A; Książek K
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609691
[TBL] [Abstract][Full Text] [Related]
5. The Proangiogenic Capabilities of Malignant Ascites Generated by Aggressive Ovarian Tumors.
Mikuła-Pietrasik J; Uruski P; Szubert S; Maksin K; Moszyński R; Szpurek D; Woźniak A; Sajdak S; Tykarski A; Książek K
Biomed Res Int; 2017; 2017():2592496. PubMed ID: 29085834
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria-related oxidative stress contributes to ovarian cancer-promoting activity of mesothelial cells subjected to malignant ascites.
Pakuła M; Mikuła-Pietrasik J; Stryczyński Ł; Uruski P; Szubert S; Moszyński R; Szpurek D; Sajdak S; Tykarski A; Książek K
Int J Biochem Cell Biol; 2018 May; 98():82-88. PubMed ID: 29550585
[TBL] [Abstract][Full Text] [Related]
7. Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway.
Matte I; Garde-Granger P; Bessette P; Piché A
BMC Cancer; 2019 Apr; 19(1):406. PubMed ID: 31039761
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress contributes to hepatocyte growth factor-dependent pro-senescence activity of ovarian cancer cells.
Mikuła-Pietrasik J; Uruski P; Pakuła M; Maksin K; Szubert S; Woźniak A; Naumowicz E; Szpurek D; Tykarski A; Książek K
Free Radic Biol Med; 2017 Sep; 110():270-279. PubMed ID: 28652056
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells.
Ren J; Xiao YJ; Singh LS; Zhao X; Zhao Z; Feng L; Rose TM; Prestwich GD; Xu Y
Cancer Res; 2006 Mar; 66(6):3006-14. PubMed ID: 16540649
[TBL] [Abstract][Full Text] [Related]
11. Patient-derived and artificial ascites have minor effects on MeT-5A mesothelial cells and do not facilitate ovarian cancer cell adhesion.
Estermann M; Huang YL; Septiadi D; Ritz D; Liang CY; Jacob F; Drasler B; Petri-Fink A; Heinzelmann-Schwarz V; Rothen-Rutishauser B
PLoS One; 2020; 15(12):e0241500. PubMed ID: 33270665
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms.
Matte I; Lane D; Laplante C; Garde-Granger P; Rancourt C; Piché A
Int J Cancer; 2015 Jul; 137(2):289-98. PubMed ID: 25482018
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness.
Rosso M; Majem B; Devis L; Lapyckyj L; Besso MJ; Llauradó M; Abascal MF; Matos ML; Lanau L; Castellví J; Sánchez JL; Pérez Benavente A; Gil-Moreno A; Reventós J; Santamaria Margalef A; Rigau M; Vazquez-Levin MH
PLoS One; 2017; 12(9):e0184439. PubMed ID: 28934230
[TBL] [Abstract][Full Text] [Related]
14. Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer.
Yokoi A; Yoshioka Y; Yamamoto Y; Ishikawa M; Ikeda SI; Kato T; Kiyono T; Takeshita F; Kajiyama H; Kikkawa F; Ochiya T
Nat Commun; 2017 Mar; 8():14470. PubMed ID: 28262727
[TBL] [Abstract][Full Text] [Related]
15. Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells.
Mikuła-Pietrasik J; Uruski P; Matuszkiewicz K; Szubert S; Moszyński R; Szpurek D; Sajdak S; Tykarski A; Książek K
Cell Oncol (Dordr); 2016 Oct; 39(5):473-481. PubMed ID: 27444787
[TBL] [Abstract][Full Text] [Related]
16. Functional role and prognostic significance of CD157 in ovarian carcinoma.
Ortolan E; Arisio R; Morone S; Bovino P; Lo-Buono N; Nacci G; Parrotta R; Katsaros D; Rapa I; Migliaretti G; Ferrero E; Volante M; Funaro A
J Natl Cancer Inst; 2010 Aug; 102(15):1160-77. PubMed ID: 20639476
[TBL] [Abstract][Full Text] [Related]
17. Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis.
Slack-Davis JK; Atkins KA; Harrer C; Hershey ED; Conaway M
Cancer Res; 2009 Feb; 69(4):1469-76. PubMed ID: 19208843
[TBL] [Abstract][Full Text] [Related]
18. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H.
Cannistra SA; Kansas GS; Niloff J; DeFranzo B; Kim Y; Ottensmeier C
Cancer Res; 1993 Aug; 53(16):3830-8. PubMed ID: 8339295
[TBL] [Abstract][Full Text] [Related]
19. Malignant ascites increases the antioxidant ability of human ovarian (SKOV-3) and gastric adenocarcinoma (KATO-III) cells.
Yang W; Toffa SE; Lohn JW; Seifalian AM; Winslet MC
Gynecol Oncol; 2005 Feb; 96(2):430-8. PubMed ID: 15661232
[TBL] [Abstract][Full Text] [Related]
20. Senescent peritoneal mesothelium creates a niche for ovarian cancer metastases.
Mikuła-Pietrasik J; Uruski P; Sosińska P; Maksin K; Piotrowska-Kempisty H; Kucińska M; Murias M; Szubert S; Woźniak A; Szpurek D; Sajdak S; Piwocka K; Tykarski A; Książek K
Cell Death Dis; 2016 Dec; 7(12):e2565. PubMed ID: 28032864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
